Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2026-05-13 16:32:07 ET · period of report 2026-05-11 · accession 0001434647-26-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-13 16:32 | 2026-05-11 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance | S - Sale | $11.30 | -1,794 | 48.1K | -4% | -$20.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-11 | S | D | 1,794 | $11.30 | 48,125 | D | — | — | (F1) Adoption date of referenced 10b5-1(c) plan is: 01-08-2026 |